Provided by Tiger Trade Technology Pte. Ltd.

Quanterix Corp

3.21
-0.1150-3.46%
Post-market: 3.220.0100+0.31%17:11 EDT
Volume:606.07K
Turnover:1.93M
Market Cap:151.08M
PE:-1.23
High:3.25
Open:3.25
Low:3.06
Close:3.33
52wk High:8.77
52wk Low:2.15
Shares:47.06M
Float Shares:38.02M
Volume Ratio:0.90
T/O Rate:1.59%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.6200
EPS(LYR):-2.5130
ROE:-46.48%
ROA:-16.67%
PB:0.64
PE(LYR):-1.28

Loading ...

Alzpath and Quanterix Expand Strategic Licensing Agreement to Advance Next Generation Alzheimer's Disease Biomarker Research

THOMSON REUTERS
·
Oct 07

Quanterix, Innovita Expand China Diagnostics Partnership with NMPA Approvals for SIMOA Instruments, Neurology Assays

Reuters
·
Oct 07

Quanterix and Innovita Expand Ivd Access in China with National Medical Products Administration Approvals

THOMSON REUTERS
·
Oct 07

Quanterix Corporation - Innovita Plans Regulatory Submissions for Additional Quanterix Biomarker Kits in China

THOMSON REUTERS
·
Oct 07

Quanterix Spotlights Spatial Biology Assay Pipeline Updates at ESSB 2026

Reuters
·
Sep 25

Quanterix Launches PhenoCode 2.0 Molecular Barcoding Kit for Spatial Biology Assays

Reuters
·
Sep 25

Quanterix Grants 260,315 RSUs to New Chief Commercial Officer James Gute Under Inducement Plan

Reuters
·
Sep 17

Quanterix Corporation Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Sep 17

Quanterix appoints Yuri Fesko as CMO

TIPRANKS
·
Sep 14

Quanterix Names Yuri Fesko as Chief Medical Officer

Reuters
·
Sep 14

Quanterix Names DR. Yuri Fesko Chief Medical Officer

THOMSON REUTERS
·
Sep 14

Quanterix Files Form 3 for Chief Commercial Officer James Edward Gute Jr

Reuters
·
Aug 19

Quanterix is Maintained at Hold by Canaccord Genuity

Dow Jones
·
Aug 17

Quanterix Director William P. Donnelly Reports Purchase of USD 286,709 in Common Shares

Reuters
·
Aug 15

Sera Prognostics Q2 Revenue Rises on Expanded Partnerships and Medicaid Coverage

Reuters
·
Aug 13

MaxCyte Q2 Revenue Beats Estimates

Reuters
·
Aug 13

Bio-Techne Q4 Revenue Rises 3%, Beats Estimates

Reuters
·
Aug 12

Annexon Biosciences Q2 Net Loss Widens, Cash Runway Extended

Reuters
·
Aug 12

Codexis Q2 Net Loss Narrows, Helped by Lower Operating Expenses

Reuters
·
Aug 12

Harvard Bioscience Q2 Revenue Rises on Telemetry Demand, Lifts 2026 Outlook

Reuters
·
Aug 11